These are the two FTSE 100 dividend stocks I bought in April 2020

I added two battered FTSE 100 dividend-paying stocks (and one from FTSE 250) to my portfolio because I believe they are good long-term investments.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Some FTSE 100 dividend-paying stocks look like absolute bargains at the moment. Here are two that I purchased recently, and a bonus one from the FTSE 250.

Addictive dividends

The popularity of reduced harm products, such as vaping devices, has hurt traditional smoking product sales. But, British American Tobacco (LSE: BATS) has been increasing its revenues by gobbling up market share.

The bulk of legal and regulatory battles concerning traditional tobacco products is in the past. The latest hit to the industry is the menthol ban in Europe and some states in the US. There is not much left to regulate now, short of an outright ban on tobacco sales, which is unlikely. 

Although the consensus view is that vaping is less harmful than inhaling burning tobacco, the absolute risks of reduced harm products are not well understood. However, the risks of cigarette smoking are well known and publicised.

The market for vaping products is ripe for regulation. This means that smokers may be put off switching as the range of vaping products shrinks and becomes more expensive. Even if vaping use skyrockets, BAT has a compelling range of reduced harm products lined up.

Dividends have grown consistently for BAT shareholders at 4% per year if you ignore the effects of the special dividend paid in 2017. I am confident that growth will continue. BAT recently announced that a biotech subsidiary is developing a potential coronavirus vaccine. BAT may get a reputational boost from this, but more importantly, it serves as a reminder of the level of scientific sophistication at big tobacco companies. If the reduced harm products do dominate, BAT has an edge in developing new products and proving their relative safety.

It’s good to talk

The dividend yield on shares in BT Group has increased from a little under 3% to near 13% over five years, but don’t be fooled. The increasing yield came from the share price falling rather than dividend payouts soaring. However, I believe BT’s share price reflects the woes of recent years.

BT Group can now get on with integrating EE, the mobile network it purchased in 2017, and fully capitalise on its position as the UK’s leading fixed-line and wireless network operator that also delivers content. You can read more about why I like BT here.

Big brand bet

PZ Cussons sells its branded consumer staples across Europe and the Americas, Asia, and Africa. Profits have been trending lower since 2017, mainly due to Cussons’ portfolio of brands becoming bloated and its Nigerian business suffering in a weak economy.

Cussons is now focusing on its core personal care and beauty brands. Shedding a Nigerian dairy business and a small Polish personal care brand are cash-generating steps in the right direction. A new CEO, snatched from Avon with 21 years prior experience at Procter & Gamble, will help with the re-focus.

As Wise Funds asset manager Philip Matthews has pointed out, there is optionality on the Nigerian business. The Nigerian economy either recovers, boosting the value of the business, or it does not. Cussons’ stock price reflects the latter option already. Either way, the stock offers an attractive yield of around 4.5% assuming no cuts, and the balance sheet is healthy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James J. McCombie owns shares in British American Tobacco, BT Group and PZ Cussons. The Motley Fool UK owns shares of PZ Cussons. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »